Private investing through venture capital vehicles is an important driver of the US economy and the source of much innovation. The start to 2022 for the industry is mixed because while fundraising, and investing in firms, appears strong, many recent exits don’t look so good, which may clog up the back end of the cycle. About 200 financings of $100 million or more were announced in the first quarter, but deal size and valuation for late-stage companies declined, likely reflecting the complete evaporation of IPOs and a decline in M & A activity. Investors begin to worry about their exits in late-stage firms. Fundraising appeared strong, with $70B in new fund commitments announced, but much of this reflects activity that actually occurred last year, with closings just now being finalized. Fundraising is likely to slow as exits slow. (NVCA Report)
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Sidekick Health welcomes new investors, who pumped $55 million into “digital therapeutics”, another over-hyped supposedly disruptive health care trend. This involves the typical phone apps, etc. that will instantly make...
May 7, 2022
A company called Hello Heart raises a fresh $70 million in capital for yet another app that supposedly helps improve management of cardiac health. I despair about the sanity of...
May 3, 2022
Having private investors own health care facilities isn’t all bad. They may jack prices up mercilessly, but they don’t appear to hurt outcomes for care and may even improve them,...
April 30, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace